Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Other Stocks, New, 2022 Q3, Page 3

CITADEL ADVISORS LLC historic quarter change: USA Other Stocks, New

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 8,173 positions, added to 6,540, reduced 6,603 and sold out of 7,821.

  • Q3 2022: Stock MOLECULIN BIOTECH INC; Country of operation —; Class COM; Shares before 0.
  • Q3 2022: Stock SYNLOGIC INC; Country of operation —; Class COM; Shares before 0.
  • Q3 2022: Stock BIOSIG TECHNOLOGIES INC; Country of operation —; Class COM NEW; Shares before 0.
  • Q3 2022: Stock TITAN PHARMACEUTICALS INC DE; Country of operation —; Class COM NEW; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2022MOLECULIN BIOTECH INC
CUSIP 60855D200
—COM013,631+13,631$0$14+$142022-11-14
Q3 2022SYNLOGIC INC
CUSIP 87166L100
—COM014,998+14,998$0$14+$142022-11-14
Q3 2022BIOSIG TECHNOLOGIES INC
CUSIP 09073N201
—COM NEW021,776+21,776$0$14+$142022-11-14
Q3 2022TITAN PHARMACEUTICALS INC DE
CUSIP 888314606
—COM NEW013,076+13,076$0$14+$142022-11-14
Q3 2022SHARPS TECHNOLOGY INC
CUSIP 82003F101
—COMMON STOCK012,253+12,253$0$14+$142022-11-14
Q3 2022EDIBLE GARDEN AG INC
CUSIP 28059P105
—COM022,634+22,634$0$14+$142022-11-14
Q3 2022UNIQUE FABRICATING INC
CUSIP 90915J103
—COM028,341+28,341$0$14+$142022-11-14
Q3 2022MATINAS BIOPHARMA HLDGS INC
CUSIP 576810105
—COM020,801+20,801$0$13+$132022-11-14
Q3 2022ENGINE GAMING AND MEDIA INC
CUSIP 29287W102
—COM023,129+23,129$0$13+$132022-11-14
Q3 2022FIRSTHAND TECHNOLOGY VALUE F
CUSIP 33766Y100
—COM010,167+10,167$0$13+$132022-11-14
Q3 2022VYANT BIO INC
CUSIP 92942V109
—COM021,558+21,558$0$12+$122022-11-14
Q3 2022NEW CONCEPT ENERGY INC
CUSIP 643611106
United StatesCOM011,072+11,072$0$12+$122022-11-14
Q3 2022EASTSIDE DISTILLING INC
CUSIP 277802302
—COM043,636+43,636$0$12+$122022-11-14
Q3 2022ABVC BIOPHARMA INC
CUSIP 00091F106
—COM012,612+12,612$0$11+$112022-11-14
Q3 2022BIOMX INC
CUSIP 09090D103
—COM031,945+31,945$0$11+$112022-11-14
Q3 2022HEPION PHARMACEUTICALS INC
CUSIP 426897104
—COM021,561+21,561$0$11+$112022-11-14
Q3 2022PAINREFORM LTD
CUSIP M77798102
—SHS015,239+15,239$0$11+$112022-11-14
Q3 2022ASPEN GROUP INC
CUSIP 04530L203
—COM NEW029,896+29,896$0$11+$112022-11-14
Q3 2022IT TECH PACKAGING INC
CUSIP 46527C209
—COM NEW014,581+14,581$0$11+$112022-11-14
Q3 2022ACASTI PHARMA INC
CUSIP 00430K873
—CL A017,826+17,826$0$10+$102022-11-14
Q3 2022ELYS GAME TECHNOLOGY CORP
CUSIP 290734102
—COM021,947+21,947$0$10+$102022-11-14
Q3 2022SESEN BIO INC
CUSIP 817763105
—COM023,094+23,094$0$10+$102022-11-14
Q3 2022SUPERIOR DRILLING PRODS INC
CUSIP 868153107
—COM014,362+14,362$0$10+$102022-11-14
Q3 2022CYCLERION THERAPEUTICS INC
CUSIP 23255M105
—COM010,651+10,651$0$9+$92022-11-14
Q3 2022GROM SOCIAL ENTERPRISES INC
CUSIP 39878L308
—COM NEW027,856+27,856$0$9+$92022-11-14
Q3 2022QUANERGY SYSTEMS INC
CUSIP 74764U104
—COM045,441+45,441$0$9+$92022-11-14
Q3 2022NEUBASE THERAPEUTICS INC
CUSIP 64132K102
—COM022,799+22,799$0$9+$92022-11-14
Q3 2022ALPINE 4 HOLDINGS INC
CUSIP 02083E105
—CL A016,526+16,526$0$9+$92022-11-14
Q3 2022NISUN INTL ENT DVPMT GP CO L
CUSIP G6593L106
—COM CL A014,169+14,169$0$7+$72022-11-14
Q3 2022SEQLL INC
CUSIP 81734C106
—COM010,820+10,820$0$7+$72022-11-14
Q3 2022PLUS THERAPEUTICS INC
CUSIP 72941H400
—COM NEW016,772+16,772$0$7+$72022-11-14
Q3 2022MAWSON INFRASTRUCTURE GROUP
CUSIP 57778N208
—COM NEW013,664+13,664$0$6+$62022-11-14
Q3 20229 METERS BIOPHARMA INC
CUSIP 654405109
—COM027,808+27,808$0$6+$62022-11-14
Q3 2022NUZEE INC
CUSIP 67073S208
—COM NEW018,996+18,996$0$6+$62022-11-14
Q3 2022REVELATION BIOSCIENCES INC
CUSIP 76135L101
—COM022,547+22,547$0$6+$62022-11-14
Q3 2022CAMBER ENERGY INC
CUSIP 13200M508
—COM024,748+24,748$0$5+$52022-11-14
Q3 2022DIRTT ENVIRONMENTAL SOLUTION
CUSIP 25490H106
—COM010,094+10,094$0$4+$42022-11-14
Q3 2022PALISADE BIO INC
CUSIP 696389105
—COM028,299+28,299$0$3+$32022-11-14
Q3 2022ZOVIO INC
CUSIP 98979V102
—COM017,544+17,544$0$3+$32022-11-14